Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide after liver transplantation for renal function preservation
IRCT20190619043942N1Phase 4Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic kidney disease (CKD) comparing Octreotide with Placebo (2 arms). Primary endpoint: Glomerular filtration. Started Jul 2021; status: completed.
02
Drugs
octreotide
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20190619043942N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190619043942N1.